World Evidence, Pricing and Access Congress

SKC is pleased to announce its participation at the World Evidence, Pricing and Access (EPA) Congress, to be held in Amsterdam from March 21^st to 23^rd, 2023. The congress ranks as one of the largest in Europe, welcoming 300 world-class speakers and over 1,200 attendees from the pharmaceutical and biotech industries.

SKC's founder and managing directors Heike Kielhorn and Prof. Matthias P. Schönermark M.D., Ph.D. are attending the congress and expect fresh input, especially on the topics "Market Access & Pricing", "Rare Diseases", "Advanced Therapies", Affordability" and "Medical Devices".

Are you also participating? Then please contact us in advance to arrange an appointment at the congress. We look forward to meeting you in Amsterdam!

Please find further information at Terrapinn: World EPA Congress.